Brief: Pacira Biosciences Q2 Revenue USD 169.5 Million Vs. IBES Estimate USD 174.6 Million
02/08/2023 13:00
Aug 02 (Reuters) - Pacira Biosciences Q2 adjusted net income USD 36 million. * Q2 cash & investments USD 220.8 million * Q2 adjusted EBITDA USD 54.3 million * Q2 net income USD 25.8 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees